1999Journal of Experimental HematologyRequires access

Protection of Paroxysmal Nocturnal Hemoglobinuria Erythrocytes by Transferring of GPI-Anchored Protein CD59 from Vesicles of Erythrocytes In Vitro

Zhinan Zhang

Open publisher page 0 citations

Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic disease characterized by sensitivity of erythrocytes to complement owing to deficiency of glycosylphosphatidylinositol (GPI)- anchored complement regulatory proteins, such as CD55 and CD59. Vesicles released from normal erythrocytes under storage or ATP depleted, are rich in CD59. PNH CD59- cells wwere separated by immuno-affinity column bound with monoclonal antibody CD59, and then incubated with normal erythrocyte vesicles. The content of CD59 and hemolysis of PNH CD59- cells were detected by flow cytometric analysis and cobra venom factor hemolytic test respectively. The fluorescence intensity of PNH CD59- cells was increased and the hemolysis was sighnificantly decreased. It seems that CD59 protein molecules might transfer from normal erythrocyte vesicles to PNH CD59- cells and retain the complement regulatory function. CD59-erythrocytes could be rendered less liable to hemolyze during complement attack.

About this research paper

What this paper is about

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic disease characterized by sensitivity of erythrocytes to complement owing to deficiency of glycosylphosphatidylinositol (GPI)- anchored complement regulatory proteins, such as CD55 and CD59. Vesicles released from normal erythrocytes under storage or ATP depleted, are rich in CD59. PNH CD59- cells wwere separated by immuno-affinity column bound with monoclonal antibody CD59, and then incubated with normal erythrocyte vesicles. The content of CD59 and hemolysis of PNH CD59- cells were detected by flow cytometric analysis and cobra venom factor hemolytic test respectively. The fluorescence intensity of PNH CD59- cells was increased and the hemolysis was sighnificantly decreased. It seems that CD59 protein molecules might transfer from normal erythrocyte vesicles to PNH CD59- cells and retain the complement regulatory function. CD59-erythrocytes could be rendered less liable to hemolyze during complement attack.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic disease characterized by sensitivity of erythrocytes to complement owing to deficiency of glycosylphosphatidylinositol (GPI)- anchored complement regulatory proteins, such as CD55 and CD59. Vesicles released from normal erythrocytes under storage or ATP depleted, are rich in CD59. PNH CD59- cells wwere separated by immuno-affinity column bound with monoclonal antibody CD59, and then incubated with normal erythrocyte vesicles. The content of CD59 and hemolysis of PNH CD59- cells were detected by flow cytometric analysis and cobra venom factor hemolytic test respectively. The fluorescence intensity of PNH CD59- cells was increased and the hemolysis was sighnificantly decreased. It seems that CD59 protein molecules might transfer from normal erythrocyte vesicles to PNH CD59- cells and retain the complement regulatory function. CD59-erythrocytes could be rendered less liable to hemolyze during complement attack.

Key concepts: Paroxysmal nocturnal hemoglobinuria, CD59, Hemolysis, Decay-accelerating factor, Vesicle, Hemoglobinuria, Complement membrane attack complex, Monoclonal antibody

Related papers

Back to paper searchBrowse research topicsOriginal source
Protection of Paroxysmal Nocturnal Hemoglobinuria Erythrocytes by Transferring of GPI-Anchored Protein CD59 from Vesicles of Erythrocytes In Vitro — Research Paper | ScholarLens